{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:26:15Z","timestamp":1793816775476,"version":"4.6.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s11427-023-2499-2","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:01:59Z","timestamp":1718841719000},"page":"1849-1866","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K\/Akt\/mTOR pathway"],"prefix":"10.1007","volume":"67","author":[{"given":"Kumar","family":"Ganesan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cailu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,17]]},"reference":[{"key":"2499_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/cbf.3266","volume":"35","author":"S Balakrishnan","year":"2017","unstructured":"Balakrishnan, S., Mukherjee, S., Das, S., Bhat, F.A., Raja Singh, P., Patra, C.R., and Arunakaran, J. (2017). Gold nanoparticles-conjugated quercetin induces apoptosis via inhibition of EGFR\/PI3K\/Akt-mediated pathway in breast cancer cell lines (MCF-7 and MDA-MB-231). Cell Biochem Funct 35, 217\u2013231.","journal-title":"Cell Biochem Funct"},{"key":"2499_CR2","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1038\/s41467-023-38115-2","volume":"14","author":"J Bi","year":"2023","unstructured":"Bi, J., Wu, Z., Zhang, X., Zeng, T., Dai, W., Qiu, N., Xu, M., Qiao, Y., Ke, L., Zhao, J., et al. (2023). TMEM25 inhibits monomeric EGFR-mediated STAT3 activation in basal state to suppress triple-negative breast cancer progression. Nat Commun 14, 2342.","journal-title":"Nat Commun"},{"key":"2499_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11427-022-2340-4","volume":"67","author":"J Cai","year":"2024","unstructured":"Cai, J., Xu, X., and Saw, P.E. (2024). Nanomedicine targeting ferroptosis to overcome anticancer therapeutic resistance. Sci China Life Sci 67, 19\u201340.","journal-title":"Sci China Life Sci"},{"key":"2499_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11427-021-2140-8","volume":"66","author":"Z Cai","year":"2023","unstructured":"Cai, Z., Wang, J., Li, Y., Shi, Q., Jin, L., Li, S., Zhu, M., Wang, Q., Wong, L.L., Yang, W., et al. (2023). Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4\/6 inhibitor in breast cancer that can be reversed by PI3K\/mTOR inhibitors. Sci China Life Sci 66, 94\u2013109.","journal-title":"Sci China Life Sci"},{"key":"2499_CR5","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1007\/s11427-023-2343-y","volume":"66","author":"G Chen","year":"2023","unstructured":"Chen, G., Sun, L., Gu, X., Ai, L., Yang, J., Zhang, Z., Hou, P., Wang, Y., Ou, X., Jiang, X., et al. (2023a). FSIP1 enhances the therapeutic sensitivity to CDK4\/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway. Sci China Life Sci 66, 2805\u20132817.","journal-title":"Sci China Life Sci"},{"key":"2499_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2478\/jtim-2021-0050","volume":"11","author":"X Chen","year":"2023","unstructured":"Chen, X., Wang, M., Yu, K., Xu, S., Qiu, P., Lyu, Z., Zhang, X., and Xu, Y. (2023b). Chronic stress-induced immune dysregulation in breast cancer: Implications of psychosocial factors. J Transl Internal Med 11, 226\u2013233.","journal-title":"J Transl Internal Med"},{"key":"2499_CR7","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/ddr.21938","volume":"83","author":"W Cheng","year":"2022","unstructured":"Cheng, W., Liu, D., Guo, M., Li, H., and Wang, Q. (2022). Sophoraflavanone G suppresses the progression of triple-negative breast cancer via the inactivation of EGFR-PI3K-AKT signaling. Drug Dev Res 83, 1138\u20131151.","journal-title":"Drug Dev Res"},{"key":"2499_CR8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-022-01601-0","volume":"21","author":"S Dong","year":"2022","unstructured":"Dong, S., Yousefi, H., Savage, I.V., Okpechi, S.C., Wright, M.K., Matossian, M.D., Collins-Burow, B.M., Burow, M.E., and Alahari, S.K. (2022). Ceritinib is a novel triple negative breast cancer therapeutic agent. Mol Cancer 21, 138.","journal-title":"Mol Cancer"},{"key":"2499_CR9","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s11427-021-2055-x","volume":"65","author":"H Feng","year":"2022","unstructured":"Feng, H., Zhao, X., Xie, J., Bai, X., Fu, W., Chen, H., Tang, H., Wang, X., and Dong, C. (2022). Pathogen-associated T follicular helper cell plasticity is critical in anti-viral immunity. Sci China Life Sci 65, 1075\u20131090.","journal-title":"Sci China Life Sci"},{"key":"2499_CR10","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1158\/2159-8290.CD-13-0945","volume":"4","author":"Y Feng","year":"2014","unstructured":"Feng, Y., Sokol, E.S., Del Vecchio, C.A., Sanduja, S., Claessen, J.H.L., Proia, T.A., Jin, D. X., Reinhardt, F., Ploegh, H.L., Wang, Q., et al. (2014). Epithelial-to-mesenchymal transition activates PERK-eIF2\u03b1 and sensitizes cells to endoplasmic reticulum stress. Cancer Discov 4, 702\u2013715.","journal-title":"Cancer Discov"},{"key":"2499_CR11","doi-asserted-by":"publisher","first-page":"105974","DOI":"10.1016\/j.phrs.2021.105974","volume":"178","author":"K Ganesan","year":"2022","unstructured":"Ganesan, K., Du, B., and Chen, J. (2022). Effects and mechanisms of dietary bioactive compounds on breast cancer prevention. Pharmacol Res 178, 105974.","journal-title":"Pharmacol Res"},{"key":"2499_CR12","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.3390\/pharmaceutics13111829","volume":"13","author":"K Ganesan","year":"2021","unstructured":"Ganesan, K., Wang, Y., Gao, F., Liu, Q., Zhang, C., Li, P., Zhang, J., and Chen, J. (2021). Targeting engineered nanoparticles for breast cancer therapy. Pharmaceutics 13, 1829.","journal-title":"Pharmaceutics"},{"key":"2499_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/ijms19010013","volume":"19","author":"K Ganesan","year":"2017","unstructured":"Ganesan, K., and Xu, B. (2017). Telomerase inhibitors from natural products and their anticancer potential. Int J Mol Sci 19, 13.","journal-title":"Int J Mol Sci"},{"key":"2499_CR14","doi-asserted-by":"publisher","first-page":"111648","DOI":"10.1016\/j.fct.2020.111648","volume":"144","author":"K Ganesan","year":"2020","unstructured":"Ganesan, K., and Xu, B. (2020). Deep frying cooking oils promote the high risk of metastases in the breast-A critical review. Food Chem Toxicol 144, 111648.","journal-title":"Food Chem Toxicol"},{"key":"2499_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/7628734","volume":"2018","author":"HAM Gomaa","year":"2018","unstructured":"Gomaa, H.A.M., Ali, A.T., Gabbar, M.A., and Kandeil, M.A. (2018). The effect of canertinib on sensitivity of cytotoxic drugs in tamoxifen-resistant breast cancer cells in vitro. Int J Genomics 2018, 1\u201310.","journal-title":"Int J Genomics"},{"key":"2499_CR16","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1007\/s11427-022-2104-3","volume":"65","author":"C Gong","year":"2022","unstructured":"Gong, C., Cheng, Z., Yang, Y., Shen, J., Zhu, Y., Ling, L., Lin, W., Yu, Z., Li, Z., Tan, W., et al. (2022a). A 10-miRNA risk score-based prediction model for pathological complete response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer. Sci China Life Sci 65, 2205\u20132217.","journal-title":"Sci China Life Sci"},{"key":"2499_CR17","doi-asserted-by":"publisher","first-page":"5122448","DOI":"10.1155\/2022\/5122448","volume":"2022","author":"G Gong","year":"2022","unstructured":"Gong, G., Ganesan, K., Xiong, Q., and Zheng, Y. (2022b). Antitumor effects of ononin by modulation of apoptosis in non-small-cell lung cancer through inhibiting PI3K\/ Akt\/mTOR pathway. Oxid Med Cell Longev 2022, 5122448.","journal-title":"Oxid Med Cell Longev"},{"key":"2499_CR18","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3390\/cancers15030758","volume":"15","author":"G Gong","year":"2023","unstructured":"Gong, G., Ganesan, K., Xiong, Q., and Zheng, Y. (2023). Anti-invasive and anti-migratory effects of ononin on human osteosarcoma cells by limiting the MMP2\/9 and EGFR-Erk1\/2 pathway. Cancers 15, 758.","journal-title":"Cancers"},{"key":"2499_CR19","doi-asserted-by":"publisher","first-page":"714322","DOI":"10.3389\/fphar.2021.714322","volume":"12","author":"J Gu","year":"2021","unstructured":"Gu, J., Sun, R., Wang, Q., Liu, F., Tang, D., and Chang, X. (2021). Standardized astragalus mongholicus Bunge-Curcuma Aromatica Salisb. extract efficiently suppresses colon cancer progression through gut microbiota modification in CT26-bearing mice. Front Pharmacol 12, 714322.","journal-title":"Front Pharmacol"},{"key":"2499_CR20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s11427-023-2423-1","volume":"67","author":"S He","year":"2024","unstructured":"He, S., Xia, C., Li, H., Cao, M., Yang, F., Yan, X., Zhang, S., Teng, Y., Li, Q., and Chen, W. (2024). Cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors. Sci China Life Sci 67, 122\u2013131.","journal-title":"Sci China Life Sci"},{"key":"2499_CR21","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.procbio.2015.03.001","volume":"50","author":"J Huang","year":"2015","unstructured":"Huang, J., Xie, M., Gao, P., Ye, Y., Liu, Y., Zhao, Y., Luo, W., Ling, Z., Cao, Y., Zhang, S., et al. (2015). Antiproliferative effects of formononetin on human colorectal cancer via suppressing cell growth in vitro and in vivo. Process Biochem 50, 912\u2013917.","journal-title":"Process Biochem"},{"key":"2499_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41419-021-04493-y","volume":"13","author":"Y Huang","year":"2022","unstructured":"Huang, Y., Liu, S., Shan, M., Hagenaars, S.C., Mesker, W.E., Cohen, D., Wang, L., Zheng, Z., Devilee, P., Tollenaar, R.A.E.M., et al. (2022). RNF12 is regulated by AKT phosphorylation and promotes TGF-\u03b2 driven breast cancer metastasis. Cell Death Dis 13, 44.","journal-title":"Cell Death Dis"},{"key":"2499_CR23","doi-asserted-by":"publisher","first-page":"4831833","DOI":"10.1155\/2022\/4831833","volume":"2022","author":"Y Hussain","year":"2022","unstructured":"Hussain, Y., Khan, H., Alam, W., Aschner, M., Abdullah, Alsharif, K.F., and Saso, L. (2022). Flavonoids targeting the mTOR signaling cascades in cancer: a potential crosstalk in anti-breast cancer therapy. Oxid Med Cell Longev 2022, 4831833.","journal-title":"Oxid Med Cell Longev"},{"key":"2499_CR24","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s11427-022-2218-x","volume":"66","author":"W Ju","year":"2023","unstructured":"Ju, W., Zheng, R., Zhang, S., Zeng, H., Sun, K., Wang, S., Chen, R., Li, L., Wei, W., and He, J. (2023). Cancer statistics in Chinese older people, 2022: current burden, time trends, and comparisons with the US, Japan, and the Republic of Korea. Sci China Life Sci 66, 1079\u20131091.","journal-title":"Sci China Life Sci"},{"key":"2499_CR25","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1158\/0008-5472.CAN-22-3964","volume":"83","author":"MA Karreman","year":"2023","unstructured":"Karreman, M.A., Bauer, A.T., Solecki, G., Berghoff, A.S., Mayer, C.D., Frey, K., Hebach, N., Feinauer, M.J., Schieber, N.L., Tehranian, C., et al. (2023). Active remodeling of capillary endothelium via cancer cell-derived MMP9 promotes metastatic brain colonization. Cancer Res 83, 1299\u20131314.","journal-title":"Cancer Res"},{"key":"2499_CR26","doi-asserted-by":"publisher","first-page":"85021","DOI":"10.18632\/oncotarget.13116","volume":"7","author":"J Kim","year":"2016","unstructured":"Kim, J., Kong, J., Chang, H., Kim, H., and Kim, A. (2016). EGF induces epithelial-mesenchymal transition through phospho-Smad2\/3-Snail signaling pathway in breast cancer cells. Oncotarget 7, 85021\u201385032.","journal-title":"Oncotarget"},{"key":"2499_CR27","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.2217\/epi-2019-0093","volume":"11","author":"Y Kong","year":"2019","unstructured":"Kong, Y., Yang, L., Wei, W., Lyu, N., Zou, Y., Gao, G., Ou, X., Xie, X., and Tang, H. (2019). CircPLK1 sponges miR-296-5p to facilitate triple-negative breast cancer progression. Epigenomics 11, 1163\u20131176.","journal-title":"Epigenomics"},{"key":"2499_CR28","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s11427-022-2108-x","volume":"65","author":"B Li","year":"2022","unstructured":"Li, B., Zheng, L., Ye, J., Zhang, C., Zhou, J., Huang, Q., Guo, Y., Wang, L., Yu, P., Liu, S., et al. (2022a). CREB1 contributes colorectal cancer cell plasticity by regulating lncRNA CCAT1 and NF-\u03baB pathways. Sci China Life Sci 65, 1481\u20131497.","journal-title":"Sci China Life Sci"},{"key":"2499_CR29","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s11427-021-2057-0","volume":"65","author":"G Li","year":"2022","unstructured":"Li, G., Li, X., Zhuang, S., Wang, L., Zhu, Y., Chen, Y., Sun, W., Wu, Z., Zhou, Z., Chen, J., et al. (2022b). Gene editing and its applications in biomedicine. Sci China Life Sci 65, 660\u2013700.","journal-title":"Sci China Life Sci"},{"key":"2499_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41586-020-2850-3","volume":"587","author":"S Li","year":"2020","unstructured":"Li, S., Liu, M., Do, M.H., Chou, C., Stamatiades, E.G., Nixon, B.G., Shi, W., Zhang, X., Li, P., Gao, S., et al. (2020). Cancer immunotherapy via targeted TGF-\u03b2 signalling blockade in TH cells. Nature 587, 121\u2013125.","journal-title":"Nature"},{"key":"2499_CR31","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.ijbiomac.2011.01.014","volume":"48","author":"YG Li","year":"2011","unstructured":"Li, Y.G., Ji, D.F., Zhong, S., Zhu, J.X., Chen, S., and Hu, G.Y. (2011). Anti-tumor effects of proteoglycan from Phellinus linteus by immunomodulating and inhibiting Reg IV\/EGFR\/Akt signaling pathway in colorectal carcinoma. Int J Biol Macromol 48, 511\u2013517.","journal-title":"Int J Biol Macromol"},{"key":"2499_CR32","doi-asserted-by":"publisher","first-page":"5420","DOI":"10.2174\/0929867329666220520121711","volume":"29","author":"Y Li","year":"2022","unstructured":"Li, Y., Ganesan, K., and Chen, J. (2022c). Role of biological mediators of tumor-associated macrophages in breast cancer progression. Curr Med Chem 29, 5420\u20135440.","journal-title":"Curr Med Chem"},{"key":"2499_CR33","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1007\/s11427-022-2329-7","volume":"66","author":"S Liu","year":"2023","unstructured":"Liu, S., Zhang, F., Liang, Y., Wu, G., Liu, R., Li, X., Saw, P.E., and Yang, Z. (2023). Nanoparticle (NP)-mediated APOC1 silencing to inhibit MAPK\/ERK and NF-\u03baB pathway and suppress breast cancer growth and metastasis. Sci China Life Sci 66, 2451\u20132465.","journal-title":"Sci China Life Sci"},{"key":"2499_CR34","first-page":"44","volume":"986\u2013987","author":"X Liu","year":"2015","unstructured":"Liu, X., Zhu, R., Hu, F., Guo, L., Yang, Y., and Feng, S. (2015). Tissue distribution of six major bio-active components after oral administration of Zhenqi Fuzheng capsules to rats using ultra-pressure liquid chromatography-tandem mass spectrometry. J Chromatogr B 986\u2013987, 44\u201353.","journal-title":"J Chromatogr B"},{"key":"2499_CR35","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1021\/acs.jafc.8b00035","volume":"66","author":"LY Luo","year":"2018","unstructured":"Luo, L.Y., Fan, M.X., Zhao, H.Y., Li, M.X., Wu, X., and Gao, W.Y. (2018). Pharmacokinetics and bioavailability of the isoflavones formononetin and ononin and their in vitro absorption in ussing chamber and Caco-2 cell models. J Agric Food Chem 66, 2917\u20132924.","journal-title":"J Agric Food Chem"},{"key":"2499_CR36","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1016\/j.devcel.2021.11.006","volume":"56","author":"F L\u00fc\u00f6nd","year":"2021","unstructured":"L\u00fc\u00f6nd, F., Sugiyama, N., Bill, R., Bornes, L., Hager, C., Tang, F., Santacroce, N., Beisel, C., Ivanek, R., B\u00fcrglin, T., et al. (2021). Distinct contributions of partial and full EMT to breast cancer malignancy. Dev Cell 56, 3203\u20133221.e11.","journal-title":"Dev Cell"},{"key":"2499_CR37","doi-asserted-by":"publisher","first-page":"153186","DOI":"10.1016\/j.phymed.2020.153186","volume":"68","author":"Z Ma","year":"2020","unstructured":"Ma, Z., Yang, J., Yang, Y., Wang, X., Chen, G., Shi, A., Lu, Y., Jia, S., Kang, X., and Lu, L. (2020). Rosmarinic acid exerts an anticancer effect on osteosarcoma cells by inhibiting DJ-1 via regulation of the PTEN-PI3K-Akt signaling pathway. Phytomedicine 68, 153186.","journal-title":"Phytomedicine"},{"key":"2499_CR38","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1038\/s41598-023-30950-z","volume":"13","author":"C Mamot","year":"2023","unstructured":"Mamot, C., Wicki, A., Hasler-Strub, U., Riniker, S., Li, Q., Holer, L., B\u00e4rtschi, D., Zaman, K., von Moos, R., Dedes, K.J., et al. (2023). A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancer. Sci Rep 13, 3705.","journal-title":"Sci Rep"},{"key":"2499_CR39","doi-asserted-by":"publisher","first-page":"289","DOI":"10.14740\/wjon1518","volume":"13","author":"WL Min","year":"2022","unstructured":"Min, W.L., Wang, B.F., Liang, B.B., Zhang, L., Pan, J.Y., Huang, Y., Zhao, Y., Lin, S., Zhao, Y.H., Zhang, S.Q., et al. (2022). A ROS\/Akt\/NF-\u03baB signaling cascade mediates epidermal growth factor-induced epithelial-mesenchymal transition and invasion in human breast cancer cells. World J Oncol 13, 289\u2013298.","journal-title":"World J Oncol"},{"key":"2499_CR40","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3390\/cells12071078","volume":"12","author":"N Nistic\u00f2","year":"2023","unstructured":"Nistic\u00f2, N., Aloisio, A., Lupia, A., Zimbo, A.M., Mimmi, S., Maisano, D., Russo, R., Marino, F., Scalise, M., Chiarella, E., et al. (2023). Development of cyclic peptides targeting the epidermal growth factor receptor in mesenchymal triple-negative breast cancer subtype. Cells 12, 1078.","journal-title":"Cells"},{"key":"2499_CR41","doi-asserted-by":"publisher","first-page":"110017","DOI":"10.1016\/j.envres.2020.110017","volume":"190","author":"A Sarfraz","year":"2020","unstructured":"Sarfraz, A., Rasul, A., Sarfraz, I., Shah, M.A., Hussain, G., Shafiq, N., Masood, M., Adem, \u015e., Sarker, S.D., and Li, X. (2020). Hispolon: A natural polyphenol and emerging cancer killer by multiple cellular signaling pathways. Environ Res 190, 110017.","journal-title":"Environ Res"},{"key":"2499_CR42","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11010-019-03640-6","volume":"463","author":"L Si","year":"2020","unstructured":"Si, L., Fu, J., Liu, W., Hayashi, T., Nie, Y., Mizuno, K., Hattori, S., Fujisaki, H., Onodera, S., and Ikejima, T. (2020). Silibinin inhibits migration and invasion of breast cancer MDA-MB-231 cells through induction of mitochondrial fusion. Mol Cell Biochem 463, 189\u2013201.","journal-title":"Mol Cell Biochem"},{"key":"2499_CR43","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1007\/s11427-022-2184-6","volume":"66","author":"S Su","year":"2023","unstructured":"Su, S. (2023). Effector Immune Cell Deployment: a revolutionized concept in cancer immunotherapy. Sci China Life Sci 66, 1930\u20131933.","journal-title":"Sci China Life Sci"},{"key":"2499_CR44","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10549-022-06783-1","volume":"197","author":"S Subham","year":"2023","unstructured":"Subham, S., Jeppson, J.D., Worcester, C., Schatmeyer, B., Zhao, J., Madan, R., Lakis, N. S., Kimler, B.F., McGuirk, J.P., Chen, R.C., et al. (2023). EGFR as a potent CAR T target in triple negative breast cancer brain metastases. Breast Cancer Res Treat 197, 57\u201369.","journal-title":"Breast Cancer Res Treat"},{"key":"2499_CR45","doi-asserted-by":"publisher","first-page":"C971","DOI":"10.1152\/ajpcell.00348.2022","volume":"324","author":"D Sulekha Suresh","year":"2023","unstructured":"Sulekha Suresh, D., and Guruvayoorappan, C. (2023). Molecular principles of tissue invasion and metastasis. Am J Physiol Cell Physiol 324, C971\u2013C991.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2499_CR46","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41467-017-00396-9","volume":"8","author":"X Tang","year":"2017","unstructured":"Tang, X., Shi, L., Xie, N., Liu, Z., Qian, M., Meng, F., Xu, Q., Zhou, M., Cao, X., Zhu, W. G., et al. (2017). SIRT7 antagonizes TGF-\u03b2 signaling and inhibits breast cancer metastasis. Nat Commun 8, 318.","journal-title":"Nat Commun"},{"key":"2499_CR47","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/1735-5362.367792","volume":"18","author":"H Vyshnavi","year":"2023","unstructured":"Vyshnavi, H., and Namboori, K. (2023). Identifying potential ligand molecules EGFR mediated TNBC targeting the kinase domain-identification of customized drugs through in silico methods. Res Pharma Sci 18, 121.","journal-title":"Res Pharma Sci"},{"key":"2499_CR48","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/jog.15493","volume":"49","author":"R Wang","year":"2023","unstructured":"Wang, R., Liu, W., Zhao, J., Liu, L., Li, S., Duan, Y., and Huo, Y. (2023a). Overexpressed LAMC2 promotes trophoblast over-invasion through the PI3K\/Akt\/MMP2\/9 pathway in placenta accreta spectrum. J Obstet Gynaecol 49, 548\u2013559.","journal-title":"J Obstet Gynaecol"},{"key":"2499_CR49","doi-asserted-by":"publisher","first-page":"103922","DOI":"10.1016\/j.jddst.2022.103922","volume":"79","author":"Y Wang","year":"2023","unstructured":"Wang, Y., Zhang, C., Xiao, M., Ganesan, K., Gao, F., Liu, Q., Ye, Z., Sui, Y., Zhang, F., Wei, K., et al. (2023b). A tumor-targeted delivery of oral isoliquiritigenin through encapsulated zein phosphatidylcholine hybrid nanoparticles prevents triple-negative breast cancer. J Drug Deliv Sci Tech 79, 103922.","journal-title":"J Drug Deliv Sci Tech"},{"key":"2499_CR50","doi-asserted-by":"publisher","first-page":"153437","DOI":"10.1016\/j.phymed.2020.153437","volume":"81","author":"HT Wu","year":"2021","unstructured":"Wu, H.T., Lin, J., Liu, Y.E., Chen, H.F., Hsu, K.W., Lin, S.H., Peng, K.Y., Lin, K.J., Hsieh, C.C., and Chen, D.R. (2021). Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT\/mTOR signaling pathway. Phytomedicine 81, 153437.","journal-title":"Phytomedicine"},{"key":"2499_CR51","doi-asserted-by":"publisher","first-page":"e262","DOI":"10.1002\/mco2.262","volume":"4","author":"B Xie","year":"2023","unstructured":"Xie, B., Chen, X., and Zhao, L. (2023). SNORA71C promotes development and metastasis of breast cancer by regulating RUNX1 and ferroptosis. MedComm 4, e262.","journal-title":"MedComm"},{"key":"2499_CR52","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3390\/cancers14030475","volume":"14","author":"C Xu","year":"2022","unstructured":"Xu, C., Ganesan, K., Liu, X., Ye, Q., Cheung, Y., Liu, D., Zhong, S., and Chen, J. (2022). Prognostic value of negative emotions on the incidence of breast cancer: a systematic review and meta-analysis of 129,621 patients with breast cancer. Cancers 14, 475.","journal-title":"Cancers"},{"key":"2499_CR53","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.bbrc.2018.05.139","volume":"502","author":"X Xu","year":"2018","unstructured":"Xu, X., Zhang, L., He, X., Zhang, P., Sun, C., Xu, X., Lu, Y., and Li, F. (2018). TGF-\u03b2 plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis. Biochem Biophys Res Commun 502, 160\u2013165.","journal-title":"Biochem Biophys Res Commun"},{"key":"2499_CR54","doi-asserted-by":"publisher","first-page":"939646","DOI":"10.3389\/fonc.2022.939646","volume":"12","author":"B Ye","year":"2022","unstructured":"Ye, B., Ma, J., Li, Z., Li, Y., and Han, X. (2022). Ononin shows anticancer activity against laryngeal cancer via the inhibition of ERK\/JNK\/p38 signaling pathway. Front Oncol 12, 939646.","journal-title":"Front Oncol"},{"key":"2499_CR55","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-023-01805-y","volume":"22","author":"F Ye","year":"2023","unstructured":"Ye, F., Dewanjee, S., Li, Y., Jha, N.K., Chen, Z.S., Kumar, A., Vishakha, A., Behl, T., Jha, S.K., and Tang, H. (2023). Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer. Mol Cancer 22, 105.","journal-title":"Mol Cancer"},{"key":"2499_CR56","first-page":"5381","volume":"12","author":"XH Yuan","year":"2020","unstructured":"Yuan, X.H., Zhang, P., Yu, T.T., Huang, H.K., Zhang, L.L., Yang, C.M., Tan, T., Yang, S.D., Luo, X.J., and Luo, J.Y. (2020). Lycorine inhibits tumor growth of human osteosarcoma cells by blocking Wnt\/\u03b2-catenin, ERK1\/2\/MAPK and PI3K\/AKT signaling pathway. Am J Transl Res 12, 5381\u20135398.","journal-title":"Am J Transl Res"},{"key":"2499_CR57","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3390\/ph15060699","volume":"15","author":"G Zg\u00f3rka","year":"2022","unstructured":"Zg\u00f3rka, G., Maciejewska-Turska, M., Makuch-Kocka, A., and Plech, T. (2022). In vitro evaluation of the antioxidant activity and chemopreventive potential in human breast cancer cell lines of the standardized extract obtained from the aerial parts of zigzag clover (Trifolium medium L.). Pharmaceuticals 15, 699.","journal-title":"Pharmaceuticals"},{"key":"2499_CR58","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.3390\/cells11182885","volume":"11","author":"F Zhang","year":"2022","unstructured":"Zhang, F., Ganesan, K., Liu, Q., and Chen, J. (2022a). A review of the pharmacological potential of Spatholobus suberectus Dunn on cancer. Cells 11, 2885.","journal-title":"Cells"},{"key":"2499_CR59","doi-asserted-by":"publisher","first-page":"5187569","DOI":"10.1155\/2021\/5187569","volume":"2021","author":"F Zhang","year":"2021","unstructured":"Zhang, F., Liu, Q., Ganesan, K., Kewu, Z., Shen, J., Gang, F., Luo, X., and Chen, J. (2021). The antitriple negative breast cancer efficacy of Spatholobus suberectus Dunn on ROS-induced noncanonical inflammasome pyroptotic pathway. Oxid Med Cell Longev 2021, 5187569.","journal-title":"Oxid Med Cell Longev"},{"key":"2499_CR60","doi-asserted-by":"publisher","first-page":"11255","DOI":"10.1038\/s41598-018-29308-7","volume":"8","author":"HW Zhang","year":"2018","unstructured":"Zhang, H.W., Hu, J.J., Fu, R.Q., Liu, X., Zhang, Y.H., Li, J., Liu, L., Li, Y.N., Deng, Q., Luo, Q.S., et al. (2018). Flavonoids inhibit cell proliferation and induce apoptosis and autophagy through downregulation of PI3K\u03b3 mediated PI3K\/AKT\/mTOR\/p70S6K\/ULK signaling pathway in human breast cancer cells. Sci Rep 8, 11255.","journal-title":"Sci Rep"},{"key":"2499_CR61","doi-asserted-by":"publisher","first-page":"116179","DOI":"10.1016\/j.taap.2022.116179","volume":"452","author":"H Zhang","year":"2022","unstructured":"Zhang, H., Weng, J., Sun, S., Zhou, J., Yang, Q., Huang, X., Sun, J., Pan, M., Chi, J., and Guo, H. (2022b). Ononin alleviates endoplasmic reticulum stress in doxorubicin-induced cardiotoxicity by activating SIRT3. Toxicol Appl Pharmacol 452, 116179.","journal-title":"Toxicol Appl Pharmacol"},{"key":"2499_CR62","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s11427-022-2210-0","volume":"66","author":"P Zhang","year":"2023","unstructured":"Zhang, P., Huang, J., Zheng, W., Chen, L., Liu, S., Liu, A., Ye, J., Zhou, J., Chen, Z., Huang, Q., et al. (2023a). Single-base resolution mapping of 2\u2032-O-methylation sites by an exoribonuclease-enriched chemical method. Sci China Life Sci 66, 800\u2013818.","journal-title":"Sci China Life Sci"},{"key":"2499_CR63","doi-asserted-by":"publisher","first-page":"216142","DOI":"10.1016\/j.canlet.2023.216142","volume":"560","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y., Chen, J., Mi, D., Ling, J., Li, H., He, P., Liu, N., Chen, Q., Chen, Y., and Huang, L. (2023b). Discovery of YH677 as a cancer stemness inhibitor that suppresses triple-negative breast cancer growth and metastasis by regulating the TGF\u03b2 signaling pathway. Cancer Lett 560, 216142.","journal-title":"Cancer Lett"},{"key":"2499_CR64","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41419-022-04690-3","volume":"13","author":"A Zhao","year":"2022","unstructured":"Zhao, A., Li, D., Mao, X., Yang, M., Deng, W., Hu, W., Chen, C., Yang, G., and Li, L. (2022). GNG2 acts as a tumor suppressor in breast cancer through stimulating MRAS signaling. Cell Death Dis 13, 260.","journal-title":"Cell Death Dis"},{"key":"2499_CR65","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12906-018-2148-2","volume":"18","author":"R Zhou","year":"2018","unstructured":"Zhou, R., Chen, H., Chen, J., Chen, X., Wen, Y., and Xu, L. (2018). Extract from Astragalus membranaceus inhibit breast cancer cells proliferation via PI3K\/AKT\/mTOR signaling pathway. BMC Complement Altern Med 18, 83.","journal-title":"BMC Complement Altern Med"},{"key":"2499_CR66","first-page":"3599","volume":"38","author":"T Zhou","year":"2017","unstructured":"Zhou, T., Zhang, A., Kuang, G., Gong, X., Jiang, R., Lin, D., Li, J., Li, H., Zhang, X., Wan, J., et al. (2017). Baicalin inhibits the metastasis of highly aggressive breast cancer cells by reversing epithelial-to-mesenchymal transition by targeting \u03b2-catenin signaling. Oncol Rep 38, 3599\u20133607.","journal-title":"Oncol Rep"},{"key":"2499_CR67","doi-asserted-by":"publisher","first-page":"114415","DOI":"10.1016\/j.jep.2021.114415","volume":"280","author":"H Zhu","year":"2021","unstructured":"Zhu, H., You, J., Wen, Y., Jia, L., Gao, F., Ganesan, K., and Chen, J. (2021). Tumorigenic risk of Angelica sinensis on ER-positive breast cancer growth through ER-induced stemness in vitro and in vivo. J Ethnopharmacol 280, 114415.","journal-title":"J Ethnopharmacol"},{"key":"2499_CR68","doi-asserted-by":"publisher","first-page":"2203699","DOI":"10.1002\/advs.202203699","volume":"10","author":"Y Zou","year":"2023","unstructured":"Zou, Y., Ye, F., Kong, Y., Hu, X., Deng, X., Xie, J., Song, C., Ou, X., Wu, S., Wu, L., et al. (2023). The single-cell landscape of intratumoral heterogeneity and the immunosuppressive microenvironment in liver and brain metastases of breast cancer. Adv Sci 10, 2203699.","journal-title":"Adv Sci"}],"updated-by":[{"DOI":"10.1007\/s11427-025-2960-7","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000}}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-023-2499-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11427-023-2499-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-023-2499-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T07:01:50Z","timestamp":1775545310000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11427-023-2499-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,17]]},"references-count":68,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["2499"],"URL":"https:\/\/doi.org\/10.1007\/s11427-023-2499-2","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,17]]},"assertion":[{"value":"16 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Erratum","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An Erratum to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11427-025-2960-7","URL":"https:\/\/doi.org\/10.1007\/s11427-025-2960-7","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author(s) declare that they have no conflict of Interest. All animal experiments were approved by the Committee on the Use of Live Animals in Teaching and Research (CULATR 5286-20) and were carried out in accordance with the Principles of Laboratory Animal Care.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance and ethics"}}]}}